Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2000) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 11.816 Q1 | 254 | 23 | 57 | 7959 | 1370 | 57 | 25.67 | 346.04 |  |
| 2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.839 Q1 | 70 | 7 | 41 | 1515 | 253 | 41 | 5.39 | 216.43 |  |
| 3 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.519 Q1 | 82 | 14 | 36 | 2827 | 202 | 36 | 4.12 | 201.93 | |
| 4 | Advances in Pharmacology | journal | 0.938 Q1 | 86 | 29 | 332 | 4343 | 722 | 316 | 4.69 | 149.76 | |
| 5 | Pharmacology and Therapeutics | journal | 3.095 Q1 | 233 | 75 | 171 | 10888 | 1281 | 170 | 6.70 | 145.17 | |
| 6 | Current Drug Targets | journal | 119 | 21 | 0 | 2895 | 0 | 0 | 0.00 | 137.86 |  | |
| 7 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 |  |
| 8 | Expert Opinion on Therapeutic Targets | journal | 0.146 Q3 | 106 | 44 | 158 | 5137 | 29 | 156 | 0.32 | 116.75 | |
| 9 | Current Drug Metabolism | journal | 122 | 20 | 0 | 2311 | 0 | 0 | 0.00 | 115.55 |  | |
| 10 | Food and Drug Law Journal | journal | 0.279 Q3 | 23 | 41 | 151 | 4578 | 61 | 151 | 0.41 | 111.66 | |
| 11 | Current Medicinal Chemistry | journal | 1.491 Q1 | 202 | 72 | 115 | 7754 | 460 | 109 | 4.52 | 107.69 | |
| 12 | Progress in Medicinal Chemistry | journal | 0.600 Q2 | 38 | 6 | 19 | 646 | 37 | 11 | 2.31 | 107.67 | |
| 13 | Current Pharmaceutical Design | journal | 1.170 Q1 | 183 | 118 | 137 | 11629 | 406 | 126 | 2.91 | 98.55 | |
| 14 | Medicinal Research Reviews | journal | 1.338 Q1 | 150 | 22 | 71 | 2038 | 266 | 70 | 3.35 | 92.64 | |
| 15 | Drug Safety | journal | 0.961 Q1 | 140 | 75 | 226 | 6578 | 812 | 219 | 3.38 | 87.71 | |
| 16 | IDrugs : the investigational drugs journal | journal | 0.144 Q3 | 39 | 69 | 241 | 5920 | 63 | 237 | 0.26 | 85.80 | |
| 17 | Cellular and Molecular Life Sciences | journal | 2.400 Q1 | 261 | 182 | 480 | 14983 | 1747 | 474 | 3.79 | 82.32 |  |
| 18 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | |
| 19 | Clinical Pharmacokinetics | journal | 1.632 Q1 | 184 | 68 | 207 | 5484 | 1126 | 200 | 4.40 | 80.65 | |
| 20 | Expert Opinion on Pharmacotherapy | journal | 0.119 Q4 | 93 | 89 | 16 | 6820 | 4 | 16 | 0.25 | 76.63 | |
| 21 | Annual Report of Shionogi Research Laboratory | journal | 0.235 Q3 | 2 | 2 | 6 | 143 | 2 | 6 | 0.25 | 71.50 |  |
| 22 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | |
| 23 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | |
| 24 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | |
| 25 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | | |
| 26 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 51 | 153 | 3161 | 4 | 153 | 0.03 | 61.98 | |
| 27 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.126 Q4 | 5 | 19 | 59 | 1135 | 16 | 57 | 0.25 | 59.74 |  |
| 28 | Investigational New Drugs | journal | 0.704 Q1 | 97 | 36 | 130 | 2116 | 264 | 129 | 1.40 | 58.78 | |
| 29 | Drug Resistance Updates | journal | 0.690 Q1 | 132 | 48 | 107 | 2692 | 188 | 99 | 1.76 | 56.08 | |
| 30 | Pharmacogenomics | journal | 100 | 35 | 0 | 1937 | 0 | 0 | 0.00 | 55.34 | | |
| 31 | Prostaglandins and Other Lipid Mediators | journal | 0.428 Q2 | 86 | 58 | 222 | 3166 | 358 | 221 | 1.15 | 54.59 | |
| 32 | Current Opinion in Drug Discovery and Development | journal | 0.669 Q1 | 85 | 77 | 83 | 3924 | 161 | 78 | 1.94 | 50.96 | |
| 33 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | |
| 34 | Canadian Journal of Physiology and Pharmacology | journal | 0.647 Q2 | 95 | 131 | 467 | 6574 | 797 | 465 | 1.26 | 50.18 |  |
| 35 | Drugs of the Future | journal | 0.237 Q3 | 46 | 85 | 701 | 4223 | 345 | 701 | 0.99 | 49.68 |  |
| 36 | In Vivo | journal | 0.364 Q2 | 72 | 110 | 260 | 5450 | 283 | 260 | 0.94 | 49.55 |  |
| 37 | Apoptosis : an international journal on programmed cell death | journal | 0.577 Q2 | 128 | 62 | 148 | 3054 | 189 | 148 | 0.92 | 49.26 | |
| 38 | Neuropsychopharmacology | journal | 1.965 Q1 | 249 | 153 | 369 | 7399 | 1630 | 336 | 4.47 | 48.36 | |
| 39 | Drugs of Today | journal | 0.165 Q3 | 57 | 111 | 298 | 5309 | 146 | 295 | 0.43 | 47.83 | |
| 40 | Behavioural Pharmacology | journal | 0.880 Q1 | 87 | 64 | 242 | 3008 | 467 | 231 | 1.75 | 47.00 | |
| 41 | Journal of Pharmacological and Toxicological Methods | journal | 0.389 Q2 | 83 | 56 | 183 | 2614 | 194 | 181 | 0.65 | 46.68 | |
| 42 | Addiction Biology | journal | 0.459 Q2 | 93 | 48 | 130 | 2182 | 156 | 127 | 0.93 | 45.46 | |
| 43 | Experimental and Clinical Psychopharmacology | journal | 0.932 Q1 | 101 | 71 | 141 | 3206 | 276 | 141 | 1.84 | 45.15 | |
| 44 | Expert Opinion on Therapeutic Patents | journal | 0.439 Q2 | 88 | 150 | 402 | 6755 | 392 | 397 | 1.04 | 45.03 | |
| 45 | Psychopharmacology | journal | 1.409 Q1 | 214 | 301 | 1033 | 13437 | 3447 | 1003 | 3.06 | 44.64 | |
| 46 | Toxicology and Applied Pharmacology | journal | 1.151 Q1 | 189 | 233 | 726 | 10378 | 2435 | 714 | 2.87 | 44.54 | |
| 47 | Receptors and Channels | journal | 1.269 Q1 | 44 | 19 | 76 | 846 | 137 | 76 | 1.94 | 44.53 | |
| 48 | Neuropharmacology | journal | 2.141 Q1 | 191 | 283 | 546 | 12355 | 2431 | 542 | 4.11 | 43.66 | |
| 49 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.101 Q4 | 88 | 14 | 35 | 611 | 5 | 29 | 0.14 | 43.64 | |
| 50 | International Immunopharmacology | journal | 149 | 219 | 579 | 9416 | 784 | 569 | 1.25 | 43.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data